[ad_1]
The night market summary, compiled by Dow Jones Newswires:
===
+++++ STOCK MARKETS (6:21 pm) +++++
Stand INDEX + -% + -% YTD
EuroStoxx50 3,485.84 -1.04% -6.92%
Stoxx50 3,078.02 -0.71% -9.55%
DAX 13,114.30 -1.36% -1.02%
FTSE 6,546.75 -0.80% -12.50%
CAC 5,507.55 -0.76% -7.87%
DJIA 29,908.58 -0.30% + 4.80%
S & P-500 3,645.29 -0.62% + 12.83%
Nasdaq-Comp. 12,308.51 -0.78% + 37.18%
Nasdaq-100 12,293.22 -0.88% + 40.77%
Nikkei-225 26,657.31 -0.37% + 12.68%
EUREX + -Ticks support
Bund-Futuro 178.65% +38
+++++ COMMODITY MARKETS +++++
ROHÖL last VT-Settl. + / -% +/- USD% YTD
WTI / Nymex 46.57 46.78 -0.4% -0.21 -16.9%
Brent / ICE 49.90 50.25 -0.7% -0.35 -17.6%
METALS last day before + / -% +/- USD% YTD
Gold (Spot) 1,842.32 1,836.40 + 0.3% +5.92 + 21.4%
Silver (spot) 23.99 24.03 -0.1% -0.03 + 34.4%
Platinum (Spot) 1,015.90 1,030.95 -1.5% -15.05 + 5.3%
Kupfer-Future 3.52 3.57 -1.4% -0.05 + 24.6%
The price of gold is rising slightly with the current uncertainty. Low producer prices in November gave the Fed room for further easing of monetary policy in the coming week.
+++++ US FINANCIAL MARKET +++++
Investors in US stock exchanges are showing their cautious side ahead of the weekend. The prospect of Covid-19 vaccines in the US will not lift your spirits soon. An FDA panel has voted to approve the vaccine from Biontech and Pfizer. The vote is not surprising because the UK has recently started administering the vaccine. Market participants see the looming danger of a hard Brexit as a negative factor. Traders emphasize that a trade agreement has a price. If things turn out differently, you need to correct it. Another slowing down effect is that the long-awaited economic stimulus program in the US is not moving forward. Here is a new brake on the negotiations. At least one positive sign comes from the economic side. The mood of US consumers improved more than expected in December. Walt Disney wants to expand its range of streaming services considerably, and therefore massively increase the number of subscribers in the coming years. The price shoots up 15.1 percent. Zurich is acquiring Metlife’s P&C business in the US for $ 3.94 billion. The seller’s share fell 1.4 percent. Oracle increased sales and profits in its fiscal second quarter and performed better than expected. The stock gains 0.3 percent. Broadcom falls 1.7 percent. The group exceeded expectations. However, the turnout has already accounted for 30 percent in the current year. Lululemon is less confident. Participation is down 4.9 percent.
+++++ ECONOMIC PERSPECTIVES ++++++
No further dates announced.
+++++ FINANCIAL MARKETS EUROPE +++++
Investors closed positions ahead of the weekend in light of various uncertainty factors: There were growing signs that further corona measures could be in Germany over the weekend in light of the sharp rise in the number of infections. Baden-Württemberg had already moved on, strict departure restrictions apply here from Saturday. Meanwhile, the political vagrancy surrounding a trade deal between the EU and Britain continued. No agreement was in sight. According to Prime Minister Boris Johnson, a no-deal Brexit is “very likely.” The automobile index lost 1.5 percent. Market participants saw not only general aversion to risk, but also those of lien EU Summit they agreed on new climate targets, which were described as “unrealistic.” VW, BMW and Daimler lost as much as 3 percent. Rolls-Royce lost 7.8 percent. The company now expects a larger cash outflow in 2020 than before. For the banking sector it was 1.9 percent lower. The increasing probability of failure of the Brexit negotiations weighed on what would particularly affect British banks. For this, Morgan Stanley saw a downward potential of 10 to 20 percent. Zurich lost 2.2 percent after a multi-billion dollar acquisition in the United States. However, the relief sent Grenke’s course up 9.6 percent. S&P had confirmed the credit rating, which is important for financing. Allegations of serious misconduct are unfounded. Sanofi and Glaxosmithkline have reported a delay in the development of their corona vaccine. Sanofi lost 4 percent, Glaxosmithkline 0.3 percent. Eon fell 3 percent after a downgrade from Morgan Stanley. Hellofresh jumped 6.5 percent after positive feedback from JPM and Kepler.
+++++ EXCHANGE OF FOREIGNERS +++++
Last Forex + / -% Fri, 8:20 am Thurs, 5:28 pm% YTD
EUR / USD 1.2111 -0.25% 1.2158 1.2118 + 8.0%
EUR / JPY 125.81 -0.59% 126.47 126.49 + 3.2%
EUR / CHF 1.0783 + 0.25% 1.0773 1.0761 -0.7%
EUR / GBP 0.9177 + 0.56% 0.9127 0.9121 + 8.4%
USD / JPY 103.87 -0.35% 104.02 104.39 -4.5%
GBP / USD 1.3195 -0.81% 1.3321 1.3287 -0.4%
USD / CNH (Offshore) 6.5372 + 0.00% 6.5250 6.5447 -6.2%
Bitcoin
BTC / USD 17,965.51 -1.99% 17,818.76 18,160.01 + 149.2%
The dollar index rises with the highest risk aversion at 0.2 percent. The British pound, on the other hand, is under pressure due to growing concerns about a hard Brexit, against the dollar and the euro. British Prime Minister Boris Johnson said there is a “very high probability” that negotiations with the EU will fail.
+++++ FINANCIAL MARKETS EAST ASIA +++++
The markets were divided into two parts. Even the Wall Street specifications were inconsistent. In Hong Kong, investors were betting on a future economic recovery. I buy Petroleum– and gas values. They were encouraged by the rise in the price of oil. Among oil stocks, Cnooc was up 3.5 percent and Petrochina 3.0 percent. The Shanghai market was clearly in the red. Participants also expect higher volatility in the future. There were hardly any industry trends; the market yielded in all sectors. Investors continued to focus on foreign policy developments, namely the tensions between Beijing and Washington. In Korea, the Kospi returned to its record course, boosted by strong export figures in early December. The expectation of a rebound in the world economy was particularly evident in shipyard inventories, where Korea Shipbuilding & Offshore rose 6.8% and Hyundai Mipo Dockyard rose 8.3%. The Australian market fell, while the leading index rose for the sixth consecutive week. Both the market and the mood were depressed by the pharmaceutical company CSL, which had to withdraw a corona vaccine candidate. CSL fell 3.2 percent. In the oil sector, Santos was more expensive than 3 percent. Shares of Chinese smartphone maker Xiaomi rose 0.9 percent to an all-time high. Investors are betting on a growing market share. The reason was the obstacles to rival Huawei for the US sanctions.
+++++ COMPANY NOTIFICATIONS FROM 1.30 PM +++++
EU Commission approves joint venture between Deutsche Telekom and SKT
Deutsche Telekom has received the green light from the EU Commission for its 5G technology joint venture with South Korean SK Telecom. The joint venture will develop radio frequency repeater technology and license the resulting intellectual property rights to third parties. Since activities in the European Economic Area are negligible, the transaction does not pose any competition concerns, the Brussels Commission said.
Eon’s supervisory board discusses CEO Teyssen’s successor
Next Tuesday (December 15), the supervisory board of the energy provider Eon will meet at its next meeting to discuss the successor to the top management. Eon’s boss Johannes Teyssen’s contract expires at the end of 2021, so the supervisory board will take up the position “on time,” a company spokesman said. According to a report by Spiegel, Leonhard Birnbaum, a long-time Teyssen confidant, responsible for integrating the former RWE Innogy subsidiary into the group’s board of directors, has a good chance.
Thyssenkrupp: state participation is off the table
The steel company Thyssenkrupp rejects the entry of the state. “The issue of state participation is off the table,” Klaus Keysberg, Thyssenkrupp’s chief financial officer, told Rheinische Post. “After intensive examination and good discussions with the federal government and the state government of North Rhine-Westphalia, we agreed that the economic stabilization fund is not the appropriate means to support the steel division of the company with registered capital in the Current situation”.
Merck’s Bavencio drug receives EU approval recommendation for bladder cancer
(MORE TO FOLLOW) Dow Jones Newswires
December 11, 2020 12:35 ET (17:35 GMT)
